The effect of sibutramine-assisted weight loss in men with obstructive sleep apnoea
The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Abstract
Objective Obstructive sleep apnoea (OSA) occurs frequently in obese patients and may be reversible with weight loss. Obstructive sleep apnoea and obesity are both independent risk factors for hypertension and increased sympathetic activity. Sibutramine has been increasingly used in the management of obesity, but is relatively contraindicated in patients with hypertension. No studies have investigated the effect of sibutramine on OSA, blood pressure and heart rate. We aimed to assess the changes in OSA and cardiovascular parameters in obese men with OSA enrolled in a sibutramine-assisted weight loss programme (SIB-WL).Design Open uncontrolled cohort study of obese male subjects with OSA in an SIB-WL.Subjects Eighty-seven obese (body mass index =34.2+/-2.8 kg/m(2)) middle-aged (46.3+/-9.3 years) male subjects with symptomatic OSA (Epworth score 13.4+/-3.6; respiratory disturbance index (RDI) 46.0+/-23.1 events/h) completed the study.Results At 6 months, there was significant weight loss (8.3+/-4.7 kg, P<0.0001), as well as a reduction in waist and neck circumference and sagittal height (all P<0.0001). These changes were accompanied by a reduction in OSA severity (RDI fell by 16.3+/-19.4 events/h and Epworth score by 4.5+/-4.6), both P<0.0001). There was no significant change to systolic (P=0.07) or diastolic blood pressure (P=0.87); however, there was a mild rise in resting heart rate (P<0.0001).Conclusion Moderate (approximately 10%) weight loss with SIB-WL results in improvement in OSA severity without increase in blood pressure in closely monitored OSA subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An improvement of sleepiness based on self-assessment scales was reported after diet and behavioural management, and after surgery, and after pharmaceutical weight reduction 31–41.”
From Non-CPAP therapies in obstructive sleep apnoea (2011) · cites this paper as [32]
In the citing paper
“In the pharmaceutical intervention studies, change in BMI was between 1.8 and 2.6 kg·m−2, accompanied by a decrease of the AHI between 2.8 and 16.3 h−1 (7–35.6%) (table e4) 32–34.”
From Non-CPAP therapies in obstructive sleep apnoea (2011) · cites this paper as [32]
Citations
Cites
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., & Badr, S. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304293281704 · Cited by 10,183
Principles and Practice of Sleep Medicine
(2011) · Elsevier eBooks · doi:10.1016/c2009-0-59875-3 · Cited by 5,088
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension
Peppard, P. E., Young, T., Palta, M., & Skatrud, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005113421901 · Cited by 4,973
Epidemiology of Obstructive Sleep Apnea: A Population Health Perspective
Young, T., Peppard, P. E., & Gottlieb, D. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109080 · Cited by 4,244
McNicholas, W. T., Strohl, K. P., White, D. P., Levy, P. A., Schmidt, W., Wheatley, J. R., Redline, S. S., Carley, D. W., Buysse, D. J., Young, T. B., et al. (1999) · PubMed · Cited by 3,665
Nieto, F. J. (2000) · JAMA · doi:10.1001/jama.283.14.1829 · Cited by 3,369
Malhotra, A., & White, D. P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09464-3 · Cited by 1,190
Cited by
Obstructive sleep apnoea syndrome
Lévy, P., Kohler, M., McNicholas, W. T., Barbé, F., McEvoy, R. D., Somers, V. K., Lavie, L., & Pépin, J.-L. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.15 · Cited by 1,235
on behalf of the SCALE study group, Blackman, A., Foster, G. D., Zammit, G., Rosenberg, R., Aronne, L., Wadden, T., Claudius, B., Jensen, C. B., & Mignot, E. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.52 · Cited by 583
Non-CPAP therapies in obstructive sleep apnoea
Randerath, W. J., Verbraecken, J., Andreas, S., Bettega, G., Boudewyns, A., Hamans, E., Jalbert, F., Paoli, J. R., Sanner, B., Smith, I., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00099710 · Cited by 388
Obesity and craniofacial structure as risk factors for obstructive sleep apnoea: Impact of ethnicity
SUTHERLAND, K., LEE, R. W. W., & CISTULLI, P. A. (2012) · Respirology · doi:10.1111/j.1440-1843.2011.02082.x · Cited by 253
Recommendations for the management of patients with obstructive sleep apnoea and hypertension
Parati, G., Lombardi, C., Hedner, J., Bonsignore, M. R., Grote, L., Tkacova, R., Lévy, P., Riha, R., Bassetti, C., Narkiewicz, K., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00226711 · Cited by 227
Self-citationMarshall, N. S., Yee, B. J., Desai, A. V., Buchanan, P. R., Wong, K. K., Crompton, R., Melehan, K. L., Zack, N., Rao, S. G., Gendreau, R. M., et al. (2008) · Sleep · doi:10.1093/sleep/31.6.824 · Cited by 224
Self-citationParati, G., Lombardi, C., Hedner, J., Bonsignore, M. R., Grote, L., Tkacova, R., Levy, P., Riha, R., Bassetti, C., Narkiewicz, K., et al. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e328350e53b · Cited by 220
Self-citationObesity and obstructive sleep apnea – Clinical significance of weight loss
Tuomilehto, H., Seppä, J., & Uusitupa, M. (2013) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2012.08.002 · Cited by 215
Obesity, obstructive sleep apnoea and metabolic syndrome
LAM, J. C. M., MAK, J. C. W., & IP, M. S. M. (2012) · Respirology · doi:10.1111/j.1440-1843.2011.02081.x · Cited by 198
Ashrafian, H., Toma, T., Rowland, S. P., Harling, L., Tan, A., Efthimiou, E., Darzi, A., & Athanasiou, T. (2015) · Obesity Surgery · doi:10.1007/s11695-014-1533-2 · Cited by 195
“12 NS NS 66.5 50.3 Kansanen [30]a Diet 15 3 38.1 35.1 29 18 Sampol [35] Diet 67 NS 31.5 25.9 52.3 44.2 Sampol [35] (Cured Patients) Diet + exercise 24 11.5 32.8 27.2 44.3 3 Sampol [35]a (Cured Patients) Diet + exercise 24 94.3 32.8 30.8 44.3 26.4 Martinez [78] Sibutramine 10 1 25–35 Kg/m2 NS 28 27 Yee [40]a Sibutramin…”
InfluentialWinslow, D. H., Bowden, C. H., DiDonato, K. P., & McCullough, P. A. (2012) · Sleep · doi:10.5665/sleep.2204 · Cited by 163
Messineo, L., Bakker, J. P., Cronin, J., Yee, J., & White, D. P. (2024) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2024.101996 · Cited by 185
Hoyos, C. M., Yee, B. J., Phillips, C. L., Machan, E. A., Grunstein, R. R., & Liu, P. Y. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0525 · Cited by 145
Self-citationGrunstein, R. R., Stenlöf, K., Hedner, J. A., Peltonen, M., Karason, K., & Sjöström, L. (2007) · SLEEP · doi:10.1093/sleep/30.6.703 · Cited by 156
Self-citationAdipose tissue in obesity and obstructive sleep apnoea
Bonsignore, M. R., McNicholas, W. T., Montserrat, J. M., & Eckel, J. (2012) · European Respiratory Journal · doi:10.1183/09031936.00047010 · Cited by 137
The Relationship of Obesity and Obstructive Sleep Apnea
Shah, N. A., & Roux, F. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.05.012 · Cited by 160
Effect of weight loss on upper airway size and facial fat in men with obstructive sleep apnoea
Sutherland, K., Lee, R. W. W., Phillips, C. L., Dungan, G., Yee, B. J., Magnussen, J. S., Grunstein, R. R., & Cistulli, P. A. (2011) · Thorax · doi:10.1136/thx.2010.151613 · Cited by 119
Self-citationHoyos, C. M., Killick, R., Yee, B. J., Grunstein, R. R., & Liu, P. Y. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04413.x · Cited by 118
Self-citationTaranto-Montemurro, L., Messineo, L., & Wellman, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111846 · Cited by 110
“[31] tested the effect of sibutramine, a serotonin and norepinephrine reuptake inhibitor, in combination with a weight loss program, in 87 middle-aged obese patients with OSA.”
BackgroundMetabolic surgery and obstructive sleep apnoea: the protective effects of bariatric procedures
Ashrafian, H., le Roux, C. W., Rowland, S. P., Ali, M., Cummin, A. R., Darzi, A., & Athanasiou, T. (2012) · Thorax · doi:10.1136/thx.2010.151225 · Cited by 106
Obesity and obstructive sleep apnea‐hypopnea syndrome
Sousa, A. G. P. D., Cercato, C., Mancini, M. C., & Halpern, A. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00478.x · Cited by 123
“Moderate (approximately 10%) weight loss with sibutramine use results in improvement in OSAHS severity without increase in blood pressure in closely monitored sleep apnea subjects (117).”
Obstructive sleep apnea syndrome as a cause of resistant hypertension
Parati, G., Ochoa, J. E., Bilo, G., Mattaliano, P., Salvi, P., Kario, K., & Lombardi, C. (2014) · Hypertension Research · doi:10.1038/hr.2014.80 · Cited by 98
The use of sibutramine in the management of obesity and related disorders: An update
Tzotzas, T., Krassas, Tziomalos, K., & Jones, A. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4027 · Cited by 88
Sibutramine‐associated adverse effects: a practical guide for its safe use
Florentin, M., Liberopoulos, E. N., & Elisaf, M. S. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2007.00425.x · Cited by 78
“Interestingly, the drug has been shown to be effective in different populations, including adolescents (19), diabetic patients (20,27), women with polycystic ovary syndrome (30), patients with non-alcoholic fatty liver disease (NAFLD) (31,32), obstructive sleep apnoea syndrome (33,34) and obesity reviews doi: 10.”
Sleep‐Disordered Breathing and Obesity: Pathophysiology, Complications, and Treatment
Leinum, C. J., Dopp, J. M., & Morgan, B. J. (2009) · Nutrition in Clinical Practice · doi:10.1177/0884533609351532 · Cited by 76
Carneiro, G., & Zanella, M. T. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.008 · Cited by 75
Obstructive Sleep Apnea in Older Adults
Norman, D., & Loredo, J. S. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2007.08.006 · Cited by 68
Obstructive Sleep Apnoea Syndrome and Weight Loss: Review
Cowan, D. C., & Livingston, E. (2012) · Sleep Disorders · doi:10.1155/2012/163296 · Cited by 75
Obesity and cardiovascular risk
Kotsis, V., Tsioufis, K. P., Antza, C., Seravalle, G., Coca, A., Sierra, C., Lurbe, E., Stabouli, S., Jelaković, B., Redón, J., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001731 · Cited by 77
Sleep disorders in morbid obesity
Akinnusi, M. E., Saliba, R. G., Porhomayon, J., & El-Solh, A. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.10.016 · Cited by 64
“Yee and coworkers [66] examined 87 men with SDB who received 24 weeks of sibutramine in an open-label, uncontrolled cohort study.”
BackgroundPhillips, C. L., Yee, B. J., Trenell, M. I., Magnussen, J. S., Wang, D., Banerjee, D., Berend, N., & Grunstein, R. R. (2009) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27595 · Cited by 46
Self-citationSibutramine versus continuous positive airway pressure in obese obstructive sleep apnoea patients
Ferland, A., Poirier, P., & Sériès, F. (2009) · European Respiratory Journal · doi:10.1183/09031936.00167308 · Cited by 43
Pharmacological treatment of sleep apnea: Current situation and future strategies
Hedner, J. A., Grote, L., & Zou, D. (2008) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2007.06.002 · Cited by 55
“5% body weight loss achieved at 6 months was accompanied by a 35% reduction in sleep-disordered breathing (RDI from 46 to 30 events/h).(103) These changes were associated with prominent changes in symptoms and metabolic indices, showing that considerable symptom relief may be obtained in patients with OSA and obesity.”
BackgroundSelf-citationEmerging Concepts in the Medical and Surgical Treatment of Obesity
Aylwin, S., & Al-Zaman, Y. (2008) · Frontiers of Hormone Research · doi:10.1159/000115368 · Cited by 41
Effects of obesity therapies on sleep disorders
Xanthopoulos, M. S., Berkowitz, R. I., & Tapia, I. E. (2018) · Metabolism · doi:10.1016/j.metabol.2018.01.022 · Cited by 42
Pharmacological approaches to the treatment of obstructive sleep apnoea
Kohler, M., Bloch, K. E., & Stradling, J. R. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780902877674 · Cited by 37
“In a recently published uncontrolled cohort study on the effects of 6 months of sibutramine, a weight loss of approximately 9% was associated with a 35% reduction in OSA severity indices and a significant improvement in subjective daytime sleepiness [81].”
BackgroundSibutramine: Balancing weight loss benefit and possible cardiovascular risk
SIMONE, G. D., & D’Addeo, G. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.03.008 · Cited by 36
Sutherland, K., Phillips, C. L., Yee, B. J., Grunstein, R. R., & Cistulli, P. A. (2015) · SLEEP · doi:10.5665/sleep.5314 · Cited by 35
Self-citationGrunstein, R. R., Wadden, T. A., Chapman, J. L., Malhotra, A., & Phillips, C. L. (2023) · SLEEP · doi:10.1093/sleep/zsad224 · Cited by 36
Self-citationHeal, D. J., & Smith, S. L. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211032475 · Cited by 36
El-Solh, A., Gould, E., Aibangbee, K. E., Jimerson, T., & Hartling, R. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2437525 · Cited by 34
“These agents had modest efficacy in reducing OSA severity [40,89].”
Obstructive Sleep Apnea as a Cardiovascular Risk Factor—Beyond CPAP
Bock, J. M., Vungarala, S., Karim, S., & Somers, V. K. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.01.027 · Cited by 38
Kasai, T., Kohno, T., Shimizu, W., Ando, S., Joho, S., Osada, N., Kato, M., Kario, K., Shiina, K., Tamura, A., et al. (2024) · Circulation Journal · doi:10.1253/circj.cj-23-0489 · Cited by 28
Clinical Manifestations and Consequences of Obstructive Sleep Apnea
Wenner, J. B., Cheema, R., & Ayas, N. (2009) · Journal of Cardiopulmonary Rehabilitation and Prevention · doi:10.1097/hcr.0b013e31819a00f1 · Cited by 28
Can Improving Sleep Influence Sleep-Disordered Breathing?
Sériès, F. (2009) · Drugs · doi:10.2165/11532000-000000000-00000 · Cited by 24
“0001) without a rise in blood pressure.([58]) In contrast, a recent open comparative trial of one year of sibutramine treatment (n = 22) versus CPAP (n = 18) in obese patients with OSA demonstrated that, despite causing a significant reduction in weight (5.”
Slow wave sleep in patients with respiratory failure
Wang, D., Piper, A. J., WONG, K. K. H., Yee, B. J., Marshall, N. S., Dijk, D., & Grunstein, R. R. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.01.007 · Cited by 25
“Introduction mean SWS was 11% [9].”
Self-citationDrug Therapy in Obstructive Sleep Apnea
Hedner, J. A., & Zou, D. (2018) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2018.03.004 · Cited by 25
Self-citationImpact of sleep-disordered breathing treatment on upper airway anatomy and physiology
Shrivastava, D. K. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.01.002 · Cited by 24
Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study
Marshall, N. S., Delling, L., Grunstein, R. R., Peltonen, M., Sjöström, C. D., Karason, K., Carlsson, L. M. S., Hedner, J. A., Stenlöf, K., & Sjöström, L. (2011) · European Respiratory Journal · doi:10.1183/09031936.00022111 · Cited by 22
Self-citationAltered positional regulation of nasal patency in patients with obstructive sleep apnoea syndrome
Hellgren, J., Yee, B. J., Dungan, G. C., & Grunstein, R. R. (2008) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-008-0701-1 · Cited by 19
Self-citationIsolation and identification of a sibutramine analogue in a healthy food for weight loss
Lai, K.-C., Liu, Y., Tseng, M.-C., Lin, Y.-Y., & Lin, J.-H. (2020) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.2440 · Cited by 15
Management of obesity in the elderly: Too much and too late?
Kennedy, R. L., Malabu, U. H., Kazi, M., & Shahsidhar, V. (2008) · The journal of nutrition health & aging · doi:10.1007/bf03008271 · Cited by 18
“Recent studies suggest that weight loss with sibutramine improves quality of life, (215) and decreases symptoms of sleep apnoea (216).”
Tahrani, A. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch22 · Cited by 15
Yee, B. J., & Grunstein, R. R. (2009) · Wiley eBooks · doi:10.1002/9781444307627.ch19 · Cited by 13
Self-citationThe pharmacotherapeutic management of obstructive sleep apnea
Marra, S., Arnaldi, D., & Nobili, L. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1652271 · Cited by 13
“nin (5-hydroxytryptamine, 5HT) and noradrenaline re-uptake inhibitor (SNRI), has been shown to induce dose-dependent weight loss [32].”
BackgroundMoreira, R. O., Valério, C. M., Hohl, A., Moulin, C., Moura, F., Trujilho, F. R., Gerchman, F., Corrêa, L. L., Mancini, M. C., de Melo, M. E., et al. (2024) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-4292-2024-0422 · Cited by 29
“…with LSCs resulted in a weight loss of 8.3 ± 4.7 kg, which was accompanied by reductions in neck circumference, obstructive sleep apnea syndrome (OSAS) severity (decrease in apnea-hypopnea index [AHI] of 16.3+/-19.4 events/h), and Epworth sleepiness scale score (decrease of 4.5+/-4.6) (21).”
InfluentialJacobs, S., Mylemans, E., Ysebaert, M., Vermeiren, E., Guchtenaere, A. D., Heuten, H., Bruyndonckx, L., Winter, B. Y. D., Hoorenbeeck, K. V., Verhulst, S. L., et al. (2021) · Sleep Medicine · doi:10.1016/j.sleep.2021.08.002 · Cited by 11
Svendsen, M., & Tonstad, S. (2011) · Nutrition Journal · doi:10.1186/1475-2891-10-21 · Cited by 11
Stratégie thérapeutique du SAHOS intégrant les traitements associés ?
Vecchierini, M.-F., Laaban, J. P., Desjobert, M., Gagnadoux, F., Chabolle, F., Meurice, J.-C., Sapène, M., Serrier, P., & Levy, P. A. (2010) · Revue des Maladies Respiratoires · doi:10.1016/s0761-8425(10)70022-x · Cited by 10
Relationships between nutritional knowledge, obesity, and sleep disorder severity
Rose, S., Pretto, J. J., Paul, C. L., Emmett, B., Hensley, M., & Henskens, F. A. (2016) · Journal of Sleep Research · doi:10.1111/jsr.12378 · Cited by 10
“(2016) 25, 350–355 Nutritional knowledge in apnea diets (Tuomilehto et al., 2009; Yee et al., 2007).”
Early‐to‐Midlife Body Mass Index Trajectories and Obstructive Sleep Apnoea Risk 10 Years Later
Qian, Y., Perret, J. L., Hamilton, G. S., Abramson, M. J., Lodge, C., Bui, D., Ali, G. B., Silva, A. P. D., Adams, R., Thompson, B. R., et al. (2025) · Respirology · doi:10.1111/resp.70002 · Cited by 7
Booth, J., Djavadkhani, Y., & Marshall, N. S. (2014) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzu011 · Cited by 6
Alnagar, A., Sinha, Y., Ahmad, A. N., Ahmed, A., & Noormohamed, M. S. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00640-0 · Cited by 4
Weight-loss treatment for OSA: medical and surgical options
Chang, C., Marshall, N. S., Yee, B. J., & Grunstein, R. R. (2010) · European Respiratory Society eBooks · doi:10.1183/1025448x.00025409 · Cited by 4
Self-citationIoachimescu, A. G., & Ioachimescu, O. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24288-2.00132-x · Cited by 3
Nuevos aspectos terapéuticos para el control de los factores de riesgo de la obesidad
Formiguera, X., & Sierra, Á. (2007) · Medicina Clínica · doi:10.1157/13100945 · Cited by 6
Losing weight in moderate to severe obstructive sleep apnoea
Marshall, N. S., & Grunstein, R. R. (2009) · BMJ · doi:10.1136/bmj.b4363 · Cited by 3
Self-citationNon-positive airway pressure therapy for obstructive sleep apnea
Jafari, B., & Roux, F. (2012) · Current Respiratory Care Reports · doi:10.1007/s13665-012-0016-y · Cited by 2
“impact of weight loss on OSA [44, 55].”
Incretins for management of obesity and obstructive sleep apnea
Hu, X., Yee, B. J., Phillips, C. L., Chapman, J. L., & Grunstein, R. R. (2025) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2025.2513516 · Cited by 2
“This trial demonstrated a strong link between pharmacological weight loss with sibutramine and resolution of OSA, with all participants who lost more than 15% body weight achieving a reduction in AHI of 50% or more [25].”
InfluentialSelf-citationPharmacotherapeutic trials for sleep-disordered breathing
Hedner, J. A., Grote, L., & Zou, D. (2016) · CRC Press eBooks · doi:10.3109/9781420020885-29 · Cited by 2
Self-citationFlood, J., Cistulli, P. A., Tong, B., Mohammadieh, A. M., de Chazal, P., & Stewart, G. M. (2026) · Expert Review of Medical Devices · doi:10.1080/17434440.2026.2625362 · Cited by 2
“Monitoring sleep health utilizing long-term wearables may also provide additional, complementary benefits (beyond OSA management), especially in conjunction with nutrition management [121], medication [122], and blood pressure devices [123,124].”
Therapeutics for Sleep-disordered Breathing
Roux, F., & Kryger, M. H. (2010) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2010.09.001 · Cited by 1
Grunstein, R. R. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00125-0 · Cited by 2
Self-citationCentral nervous system stimulants and drugs that suppress appetite
Sequeira, R. P. (2010) · Side effects of drugs annual · doi:10.1016/s0378-6080(10)32001-0 · Cited by 2
Treatment: “Whatever It Takes”
Vicini, C., Cannavicci, A., Cioccioloni, E., Meccariello, G., Cammaroto, G., Gobbi, R., Sanna, A., Toraldo, D. M., Bonetti, G. A., Passàli, F. M., et al. (2023) · Springer eBooks · doi:10.1007/978-3-031-35225-6_5 · Cited by 1
Weight Loss in the Management of Obstructive Sleep Apnea
Jones, S. F., & Chebbo, A. (2013) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2013.07.001 · Cited by 1
Medical Therapy for Obstructive Sleep Apnoea
Ong, T. H. (2011) · Proceedings of Singapore Healthcare · doi:10.1177/201010581102000405 · Cited by 1
Non-CPAP, non surgical therapies in obstructive sleep apnoea
Undugodage, C. (2014) · Journal of the Ceylon College of Physicians · doi:10.4038/jccp.v43i1-2.6816
Behavioral and Medical Interventions in Sleep-Related Breathing Disorders
Bista, S. R., & Summers, M. O. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1703-7.10015-5
Sleep Disturbances/Sleep Apnea
Parati, G., Lombardi, C., Narkiewicz, K., Wolf, J., & Ochoa, J. E. (2017) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_18
Phillips, C. L., Cayanan, E. A., & Yee, B. J. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202112-2750ed
Self-citationParati, G., Lombardi, C., & Ochoa, J. E. (2016) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-34141-5_5
Adjunctive and alternative therapies for obstructive sleep apnea
Olson, M. D., Giri, S., & Junna, M. R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822963-7.00328-5
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01447-5
Pharmacotherapeutic trials for sleep-disordered breathing
Hedner, J. A., Grote, L., & Zou, D. (2011) · Informa Healthcare eBooks · doi:10.3109/9781420020885.026
Self-citationObesity and obstructive sleep apnea: from pathophysiology to current clinical approaches
Treptow, E. C., Carneiro, G., Andersen, M. L., Drager, L. F., & Genta, P. R. (2026) · Respiratory Research & Clinical Practice · doi:10.36416/1806-3756/e20250314
Anti-obesity medications for the management of obstructive sleep apnoea
Collings, T., & Outhoff, K. (2026) · SA pharmaceutical journal. · doi:10.36303/sapj.4699
Metadata
- Authors
- Yee, B. J., Phillips, C. L., Banerjee, D., Caterson, I., Hedner, J. A., & Grunstein, R. R.
- Affiliations
- The University of Sydney (AU)
- Corresponding author
- Yee, B J
- Venue
- International Journal of Obesity
- Published
- 2006-05-02
- Volume
- 31
- Issue
- 1
- Pages
- 161-168
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W2108545876
- Cited by
- 87
- References
- 48
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 4 · 2017: 1 · 2016: 5 · 2015: 4 · 2014: 5 · 2013: 2 · 2012: 7
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- sibutramine, obstructive sleep apnea, weight loss, obesity, blood pressure, heart rate, respiratory disturbance index, cardiovascular parameters
- MeSH terms
- Adult, Aged, Appetite Depressants, Blood Pressure, Cyclobutanes, Heart Rate, Humans, Hypertension, Male, Middle Aged, Obesity, Respiration Disorders, Cohort Studies, Weight Loss, Polysomnography, Sleep Apnea, Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.